Aalders TW - Search Results

1

Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.

De Kok JB, Schalken JA, Aalders TW, Ruers TJ, Willems HL, Swinkels DW. De Kok JB, et al. Among authors: aalders tw. Int J Cancer. 2000 Jul 15;87(2):217-20. Int J Cancer. 2000. PMID: 10861477

2

Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.

Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA. Verhagen AP, et al. Among authors: aalders tw. Cancer Res. 1992 Nov 15;52(22):6182-7. Cancer Res. 1992. PMID: 1384957

3

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Umbas R, et al. Among authors: aalders tw. Cancer Res. 1992 Sep 15;52(18):5104-9. Cancer Res. 1992. PMID: 1516067

4

Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration.

Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA. Verhagen AP, et al. Among authors: aalders tw. Prostate. 1988;13(1):25-38. doi: 10.1002/pros.2990130104. Prostate. 1988. PMID: 2458583

5

Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

van der Poel HG, Mulders PF, Aalders TW, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: aalders tw. Anal Cell Pathol. 1994 Aug;7(2):153-70. Anal Cell Pathol. 1994. PMID: 7993825

6

Changes in keratin expression during the development of benign prostatic hyperplasia.

Xue Y, Smedts F, Umbas R, Aalders TW, Debruyne FM, de la Rosette JJ, Schalken JA. Xue Y, et al. Among authors: aalders tw. Eur Urol. 1997;32(3):332-8. Eur Urol. 1997. PMID: 9358223

7

Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC Study Group.

Ruijter ET, Miller GJ, Aalders TW, van de Kaa CA, Schalken JA, Debruyne FM, Boon ME. Ruijter ET, et al. Among authors: aalders tw. J Pathol. 1997 Nov;183(3):369-75. doi: 10.1002/(SICI)1096-9896(199711)183:3<369::AID-PATH929>3.0.CO;2-9. J Pathol. 1997. PMID: 9422995

8

Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group.

Ruijter E, van de Kaa C, Aalders T, Ruiter D, Miller G, Debruyne F, Schalken J. Ruijter E, et al. Mod Pathol. 1998 Mar;11(3):276-81. Mod Pathol. 1998. PMID: 9521475

9

Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma.

Xue Y, Li J, Latijnhouwers MA, Smedts F, Umbas R, Aalders TW, Debruyne FM, De La Rosette JJ, Schalken JA. Xue Y, et al. Among authors: aalders tw. Br J Urol. 1998 Jun;81(6):844-51. doi: 10.1046/j.1464-410x.1998.00659.x. Br J Urol. 1998. PMID: 9666769

10

Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression?

Xue Y, Smedts F, Latijnhouwers MA, Ruijter ET, Aalders TW, de la Rosette JJ, Debruyne FM, Schalken JA. Xue Y, et al. Among authors: aalders tw. Anticancer Res. 1998 Jul-Aug;18(4A):2679-84. Anticancer Res. 1998. PMID: 9703928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters